Literature DB >> 3756201

Solubilization and properties of Ca2+-dependent human platelet phospholipase A2.

R M Kramer, G C Checani, A Deykin, C R Pritzker, D Deykin.   

Abstract

Using a sonicated dispersion of radiolabeled 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine as substrate, we found that phospholipase A2 activity of human platelets was enhanced 2.4-fold by albumin (1 mg/ml). The enzyme was recovered predominantly in the cytosolic fraction of platelets with less than a third of its activity being associated with the membrane fraction. In the presence of 24 mM n-octyl-beta-D-glucopyranoside (octylglucoside) phospholipase A2 was effectively (more than 90%) extracted from platelet lysates without solubilization of platelet membranes. Ion exchange chromatography of the soluble enzyme yielded a phospholipase A2 of unchanged total activity and great stability. This phospholipase A2 was active only in the presence of divalent cations (Ca2+ greater than Sr2+ greater than Mg2+ = 0), required albumin for optimal activity and exhibited exclusive positional specificity for the acyl ester bond at the 2-position of 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine. Indomethacin (500 microM), mepacrine (500 microM) and N-ethylmaleimide (4 mM) inhibited the phospholipase A2 by 69, 62 and 19%, respectively. The results are discussed in the light of previous findings on human platelet phospholipase A2.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3756201     DOI: 10.1016/0005-2760(86)90248-1

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  16 in total

Review 1.  Phospholipase A2 enzymes: physical structure, biological function, disease implication, chemical inhibition, and therapeutic intervention.

Authors:  Edward A Dennis; Jian Cao; Yuan-Hao Hsu; Victoria Magrioti; George Kokotos
Journal:  Chem Rev       Date:  2011-09-12       Impact factor: 60.622

2.  Platelet signal transduction defect with Galpha subunit dysfunction and diminished Galphaq in a patient with abnormal platelet responses.

Authors:  J Gabbeta; X Yang; M A Kowalska; L Sun; N Dhanasekaran; A K Rao
Journal:  Proc Natl Acad Sci U S A       Date:  1997-08-05       Impact factor: 11.205

3.  Primary role of calcium ions in arachidonic acid release from rat platelet membranes. Comparison with human platelet membranes.

Authors:  S Nakashima; A Suganuma; A Matsui; H Hattori; M Sato; A Takenaka; Y Nozawa
Journal:  Biochem J       Date:  1989-04-01       Impact factor: 3.857

4.  The properties of a cloned human high-molecular-mass cytosolic phospholipase A2 investigated using a continuous fluorescence displacement assay: evidence for enzyme clustering on phospholipid vesicles.

Authors:  A Creaney; D J Masters; M B Needham; R D Gordon; R Mott; D C Wilton
Journal:  Biochem J       Date:  1995-03-15       Impact factor: 3.857

5.  Constant turnover of arachidonic acid and inhibition of a potassium current in Aplysia giant neurons.

Authors:  R O Carlson; I B Levitan
Journal:  J Membr Biol       Date:  1990-07       Impact factor: 1.843

6.  Extracellular Na+, but not Na+/H+ exchange, is necessary for receptor-mediated arachidonate release in platelets.

Authors:  S Krishnamurthi; W A Morgan; V V Kakkar
Journal:  Biochem J       Date:  1990-01-01       Impact factor: 3.857

7.  TLR-4 mediated group IVA phospholipase A(2) activation is phosphatidic acid phosphohydrolase 1 and protein kinase C dependent.

Authors:  Andrej Grkovich; Aaron Armando; Oswald Quehenberger; Edward A Dennis
Journal:  Biochim Biophys Acta       Date:  2009-02-20

8.  Characterization of phospholipase A2 in monocytic cell lines. Functional and biochemical aspects of membrane association.

Authors:  W Rehfeldt; R Hass; M Goppelt-Struebe
Journal:  Biochem J       Date:  1991-06-15       Impact factor: 3.857

Review 9.  Phospholipase A2 biochemistry.

Authors:  John E Burke; Edward A Dennis
Journal:  Cardiovasc Drugs Ther       Date:  2008-10-18       Impact factor: 3.727

Review 10.  Phospholipase A2 structure/function, mechanism, and signaling.

Authors:  John E Burke; Edward A Dennis
Journal:  J Lipid Res       Date:  2008-11-14       Impact factor: 5.922

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.